Anti-bacterial
Home Up Polyalkenoate Cytocompatibility Cytocompatibility 2 Knee prostheses Biodegrad. scaffold Bio-scaffold Drug Deliver Drug release Carcinogenicity Carcinogenicity 2 Ionomer glasses Anti-bacterial Anti-bacterial 2 UHMWPE UHMWPE 2 Knee implants Ceramics CERCODIM Perfluorocarbons Spinal spacer Ionomer Stability of materials IsoBone Hair follicle Membranes Orthopaedic Fixation Systems


Anti-bacterial
Contract number
BRPR-CT97-0415 Proposal number
BE-3642
Start date Duration
RTD programme
Brite-EuRam
Budget ECU
0
Coordinator
Dr R Eloy

Organisation
Biomatech SA

Street
Zone IndI
Street
n/a
City
n/a
Country
n/a Postcode
n/a
Telephone
n/a Fax
n/a
Email
n/a
Web_address
n/a
Partner
University of Milan, IT
Partner
Vygon SA, FR
Partner
Royal Technical High School Stockholm, SW
Partner
Erco S.A., GR
Partner
Humboldt-Universitat zu Berlin, D
Partner
University of Patras, GR
Partner
Universite Claude Bernard Lyon 1, FR
Partner
Forbairt Ceramics Research Centre, I
Partner
Landbouwuniversiteit Wageningen, NL
Partner
University of Siena, I
Summary
Medical Devices represent half of the nosocomial complications in the

hospital. They are related to a relative affinity of bacteria to adhere on

an artificial surface, and to develop a biofilm structure which isolates

micro-organisms from conventional therapies. End-users and

industrials are highly concerned by morbidity and health care costs of

infection. This fundamental research program is dealing with the

screening of more than 10 different surface treatment for polymers in

order to design an “anti-bacterial” interface. These techniques of

potential interest in developing antibacterial surfaces will include:-

Design of specific antibacterial activity (silver, quaternary ammonium,

carbon-like coatings + Ag, silver iodide, antiseptics).

Grafting of biological molecules within the bulk or on the surface

(heparin is of high potential interest).

Development of non-fouling surfaces concept (PEO-like, PEO repelling,

Teflon like, suprahydrophillic, microstructured). The activity of these

materials will be screened on bacterial strains and in conditions

representative of clinical use. A fundamental approach of biofilm

expression and regulation according to the different polymeric

surfaces and treatments is included as an important step for the

understanding of the effects.

Previous Next Last

Back Up Next


All text and representations on this site © L P M Lloyd-Evans & BioBridge 2000-2005
mlloydevans@biobridge.co.uk.
Designed and managed by BioPortfolio Ltd on behalf of  L P M Lloyd-Evans & BioBridge Associates.

The foundation and maintenance of this site was made possible by EC funding in project BRRT-CT97-5008 1997-2000